gsDesign (Q21300)

From MaRDI portal
Group Sequential Design
Language Label Description Also known as
English
gsDesign
Group Sequential Design

    Statements

    0 references
    0 references
    3.4.0
    12 October 2022
    0 references
    2.0-5
    1 July 2009
    0 references
    2.2-11
    13 March 2010
    0 references
    2.3-02
    7 November 2010
    0 references
    2.4-01
    20 February 2011
    0 references
    2.6-02
    2 January 2012
    0 references
    2.6-03
    19 January 2012
    0 references
    2.6-04
    13 February 2012
    0 references
    2.7-03
    9 July 2012
    0 references
    2.7-04
    11 September 2012
    0 references
    2.7-05
    23 February 2013
    0 references
    2.7-06
    17 March 2013
    0 references
    2.8-7
    2 December 2013
    0 references
    2.8-8
    3 January 2014
    0 references
    2.9-2
    23 August 2014
    0 references
    2.9-3
    10 November 2014
    0 references
    3.0-1
    1 February 2016
    0 references
    3.1.1
    7 May 2020
    0 references
    3.2.0
    14 March 2021
    0 references
    3.2.1
    12 July 2021
    0 references
    3.2.2
    3 February 2022
    0 references
    3.3.0
    27 May 2022
    0 references
    3.5.0
    20 July 2023
    0 references
    3.6.0
    12 November 2023
    0 references
    3.6.1
    13 February 2024
    0 references
    0 references
    0 references
    13 February 2024
    0 references
    Derives group sequential clinical trial designs and describes their properties. Particular focus on time-to-event, binary, and continuous outcomes. Largely based on methods described in Jennison, Christopher and Turnbull, Bruce W., 2000, "Group Sequential Methods with Applications to Clinical Trials" ISBN: 0-8493-0316-8.
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references